🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

100 mg
📊 Market median: 200.0mg (198 products) 📚 6 studies — no high-quality reviews
This product: 100mg

Other Ingredients

Microcrystalline Cellulose Gelatin Silicon Dioxide Magnesium Stearate Titanium Dioxide FD&C Blue #2

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (87% of products) Nutrient (16% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommended Use: As a dietary supplement, take 1 capsule with meals 2-3 times daily.

⚠️ Warnings & Precautions

Keep away from local space heat sources such as space heaters and radiators. Do not expose to direct sunlight or leave in vehicle exposed to sunlight. Do not allow exposure to high humidity (above 65%).

Manufactured in a facility that also processes egg, shellfish, fish, soy, peanuts, tree nuts and milk ingredients.

🧪 Formulation Notes

Description: SAN's stabilized NA-R-ALA contains the worlds first form of NA-R-ALA, the sodium salt of R-Lipoic Acid (RLA).

Note: SAN's NA-R-ALA is stabilized with Na (Sodium). One serving contains less than 1% of the daily value for sodium, an insignificant contribution to dietary sources and therefore not listed on the label. The sodium content is SAN's NA-R-ALA will not affect blood pressure levels.

Biosolv Enhanced & Stable R-Lipoic Acid 125mg NA-R-ALA

Additional Information

Storage Instructions: Protect from heat and freezing. Keep away from local space heat sources such as space heaters and radiators. Do not expose to direct sunlight or leave in vehicle exposed to sunlight. Do not allow exposure to high humidity (above 65%). Keep container tightly closed when not in use.

SAN products are manufactured under GMP (Good Manufacturing Practices) standards with stringent quality control guidelines. Additionally, each lot produced by SAN is independently tested for purity and potency by HPLC analysis to ensure only the highest quality ingredients in our innovative formulas.

Live a vibrant life!

80% purity

Plus enhanced delivery 60 full dosage servings

GMP Certified GMP Manufactured NSF Audited Facility

HPLC & FTIR Tested Quality Approved

Ver 2

Made in the U.S.A.

Product Details

UPC / SKU 6 72898 15001 5
DSLD Entry Date 2018-04-25
Product Type Non-Nutrient/Non-Botanical
Form Capsule
Brand SAN
DSLD ID 175453
Data Updated 2026-04-11

Research Evidence

21 Research Sources
52 Avg Quality Score
13 Rct
4 Meta Analysis
2 Systematic Review
2 Clinical Trial
A Alpha-lipoic acid for diabetic peripheral neuropathy
Systematic Review The Cochrane database of systematic reviews 2024
B Efficacy and Safety of the Combination of Palmitoylethanolamide, Superoxide Dismutase, Alpha Lipoic Acid, Vitamins B12, B1, B6, E, Mg, Zn and Nicotinamide for 6 Months in People with Diabetic Neuropathy
Rct Nutrients 2024
B Alpha Lipoic Acid Supplementation and Iron Homeostasis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Meta Analysis International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 2024
B Effectiveness of alpha-lipoic acid in patients with neuropathic pain associated with type I and type II diabetes mellitus: A systematic review and meta-analysis
Meta Analysis Medicine 2023
C The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Metabolism: clinical and experimental 2018
C A systematic review and meta-analysis of α-lipoic acid in the treatment of diabetic peripheral neuropathy
Meta Analysis European journal of endocrinology 2012
C Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study
Rct Endocrine, metabolic & immune disorders drug targets 2020
C A randomized, double-blind, placebo controlled study to evaluate the effect of alpha-lipoic acid on inhibition of ADP-and collagen-induced platelet aggregation ex vivo in diabetic neuropathy patients on gabapentin or pregabalin
Rct Journal of postgraduate medicine 2024
C Ranking Alpha Lipoic Acid and Gamma Linolenic Acid in Terms of Efficacy and Safety in the Management of Adults With Diabetic Peripheral Neuropathy: A Systematic Review and Network Meta-analysis
Systematic Review Canadian journal of diabetes 2024
C Effect analysis of tanshinone IIA sulfonate sodium combined with a-lipoic acid in patients with diabetes peripheral neuropathy.
Rct Pakistan journal of pharmaceutical sciences
View all evidence for Alpha Lipoic Acid →

Compare Similar Products

View all Alpha Lipoic Acid products →